Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Prevalence Of Geriatric Population
3.1.2. Advancements In Technology
3.1.3. Incidence Of Musculoskeletal Disorders
3.1.4. Surge In Research And Development
3.2. Key Restraints
3.2.1. High Cost Of Surgeries
3.2.2. Risk Associated With The Immune Response
3.2.3. Growing Popularity Of Minimally Invasive Procedures

4. Key Analytics
4.1. Impact Of Covid-19 On Biosurgery Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Model
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entry
4.3.5. Industry Rivalry
4.4. Key Buying Criteria
4.5. Key Insights
4.6. Opportunity Matrix
4.7. Vendor Landscape

5. Market By Product
5.1. Hemostatic Agents
5.2. Bone-Graft Substitutes
5.2.1. Synthetic Graft Extenders
5.2.2. Demineralized Bone Matrix
5.2.3. Bone Morphogenetic Proteins
5.2.4. Cell-Based Matrices
5.3. Surgical Sealing Agents
5.3.1. Natural
5.3.2. Synthetic
5.4. Soft-Tissue Management
5.4.1. Synthetic Mesh/Patch
5.4.2. Natural Mesh/Patch
5.5. Anti-Adhesive Agents
5.6. Staple Line Reinforcement

6. Market By Source Type
6.1. Natural
6.2. Synthetic

7. Market By Application
7.1. Orthopedic Surgery
7.2. Cardio And Thoracic Surgery
7.3. Neuro And Spine Surgery
7.4. General Surgery
7.5. Other Applications

8. Geographical Analysis
8.1. Europe
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. Germany
8.1.5.2. United Kingdom
8.1.5.3. France
8.1.5.4. Italy
8.1.5.5. Russia
8.1.5.6. Belgium
8.1.5.7. Poland
8.1.5.8. Rest Of Europe

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions, Announcements, And Divestitures
9.2. Company Profiles
9.2.1. Baxter International Inc
9.2.2. B Braun Melsungen Ag
9.2.3. Becton, Dickinson And Company (C R Bard)
9.2.4. Betatech Medical
9.2.5. Csl Limited
9.2.6. Cryolife Inc
9.2.7. Ethicon Inc (Johnson & Johnson)
9.2.8. Integra Lifesciences Holdings Corporation
9.2.9. Medtronic Plc
9.2.10. Rti Surgical
9.2.11. Sanofi
9.2.12. Smith & Nephew Plc
9.2.13. Stryker Corporation
9.2.14. Wright Medical Group Nv
9.2.15. Zimmer Biomet Holdings Inc



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Biosurgery Market, By Product, In 2020
Figure 6: Europe Biosurgery Market, By Hemostatic Agents, 2021-2028 (In $ Million)
Figure 7: Europe Biosurgery Market, By Bone-Graft Substitutes, 2021-2028 (In $ Million)
Figure 8: Europe Bone-Graft Substitutes Market, By Synthetic Graft Extenders, 2021-2028 (In $ Million)
Figure 9: Europe Bone-Graft Substitutes Market, By Demineralized Bone Matrix, 2021-2028 (In $ Million)
Figure 10: Europe Bone-Graft Substitutes Market, By Bone Morphogenetic Proteins, 2021-2028 (In $ Million)
Figure 11: Europe Bone-Graft Substitutes Market, By Cell-Based Matrices, 2021-2028 (In $ Million)
Figure 12: Europe Biosurgery Market, By Surgical Sealing Agents, 2021-2028 (In $ Million)
Figure 13: Europe Surgical Sealing Agents Market, By Natural, 2021-2028 (In $ Million)
Figure 14: Europe Surgical Sealing Agents Market, By Synthetic, 2021-2028 (In $ Million)
Figure 15: Europe Biosurgery Market, By Soft-Tissue Management, 2021-2028 (In $ Million)
Figure 16: Europe Soft-Tissue Management Market, By Synthetic Mesh/Patch, 2021-2028 (In $ Million)
Figure 17: Europe Soft-Tissue Management Market, By Natural Mesh/Patch, 2021-2028 (In $ Million)
Figure 18: Europe Biosurgery Market, By Anti-Adhesive Agents, 2021-2028 (In $ Million)
Figure 19: Europe Biosurgery Market, By Staple Line Reinforcement, 2021-2028 (In $ Million)
Figure 20: Europe Biosurgery Market, By Source Type, In 2020
Figure 21: Europe Biosurgery Market, By Natural, 2021-2028 (In $ Million)
Figure 22: Europe Biosurgery Market, By Synthetic, 2021-2028 (In $ Million)
Figure 23: Europe Biosurgery Market, By Application, In 2020
Figure 24: Europe Biosurgery Market, By Orthopedic Surgery, 2021-2028 (In $ Million)
Figure 25: Europe Biosurgery Market, By Cardio And Thoracic Surgery, 2021-2028 (In $ Million)
Figure 26: Europe Biosurgery Market, By Neuro And Spine Surgery, 2021-2028 (In $ Million)
Figure 27: Europe Biosurgery Market, By General Surgery, 2021-2028 (In $ Million)
Figure 28: Europe Biosurgery Market, By Other Applications, 2021-2028 (In $ Million)
Figure 29: Europe Biosurgery Market, Country Outlook, 2020 & 2028 (In %)
Figure 30: Germany Biosurgery Market, 2021-2028 (In $ Million)
Figure 31: United Kingdom Biosurgery Market, 2021-2028 (In $ Million)
Figure 32: France Biosurgery Market, 2021-2028 (In $ Million)
Figure 33: Italy Biosurgery Market, 2021-2028 (In $ Million)
Figure 34: Russia Biosurgery Market, 2021-2028 (In $ Million)
Figure 35: Belgium Biosurgery Market, 2021-2028 (In $ Million)
Figure 36: Poland Biosurgery Market, 2021-2028 (In $ Million)
Figure 37: Rest Of Europe Biosurgery Market, 2021-2028 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - BIOSURGERY
TABLE 2: EUROPE BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: EUROPE BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028, (IN $ MILLION)
TABLE 4: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: EUROPE BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: EUROPE SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: EUROPE SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: EUROPE BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: EUROPE BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: EUROPE BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: LEADING PLAYERS OPERATING IN EUROPE BIOSURGERY MARKET
TABLE 17: LIST OF MERGERS & ACQUISITIONS
TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 20: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES